MindBio Therapeutics Expands AI Voice Platform with Fatigue Detection Module for High-Risk Workplaces
May 21st, 2026 1:50 PM
By: Newsworthy Staff
MindBio Therapeutics is broadening its AI voice analytics platform to include fatigue detection, filing a patent for voice-based identification of neurologically active substances and fatigue, with commercial testing of kiosks on track for late Q2 2026.
MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) is expanding its AI-driven voice analytics platform to include fatigue detection alongside its existing drug and alcohol impairment screening capabilities. The company announced May 11 that it has developed a fatigue recognition system using speech analytics and proprietary artificial intelligence models, according to a news release (https://ibn.fm/4KNzG).
The fatigue prediction module will be added to MindBio's planned Edge AI Intoxication Detection Kiosks, which are being designed for high-risk workplace environments. The company has filed a patent application covering the detection of neurologically active substances and fatigue through voice analysis. Management says commercial testing of the kiosk hardware and software remains on track for late Q2 2026.
MindBio is positioning its technology as a non-invasive alternative to breath, saliva, blood and laboratory-based testing systems, with mining, aviation, transportation and construction among the initial sectors targeted for deployment. The fatigue detection capability is expected to become an additional feature within the kiosks, which are designed to identify signs of impairment without requiring physical samples.
The expansion into fatigue detection addresses a critical safety concern in industries where worker alertness is paramount. Fatigue is a known contributor to accidents in sectors such as mining, aviation, and transportation. By integrating fatigue recognition into its voice analytics platform, MindBio aims to provide a comprehensive solution for workplace safety monitoring.
MindBio Therapeutics is a biotechnology company commercializing AI-driven voice technology for drug and alcohol intoxication detection. The company's platform uses voice analysis to identify biomarkers associated with impairment, offering a rapid and non-invasive testing method.
The latest news and updates relating to MBQIF are available in the company’s newsroom at https://ibn.fm/MBQIF.
Source Statement
This news article relied primarily on a press release disributed by InvestorBrandNetwork (IBN). You can read the source press release here,
